UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PD-L1 + macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma

Experimental hematology & oncology, 2023-03, Vol.12 (1), p.32-32, Article 32

2023

Volltextzugriff (PDF)

Positron Emission Tomography/Computed Tomography Findings During Therapy Predict Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemotherapy Alone but Not in Those Who Receive Consolidation Radiation

International journal of radiation oncology, biology, physics, 2014-06, Vol.89 (2), p.384-391

2014

Volltextzugriff (PDF)

Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma

Clinical cancer research, 2022-03, Vol.28 (5), p.972-983

2022

Volltextzugriff (PDF)

The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP

Clinical lymphoma, myeloma and leukemia, 2013-02, Vol.13 (1), p.15-18

2013

Volltextzugriff (PDF)

Impact of High-Dose Chemotherapy on Peripheral T-Cell Lymphomas

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3766-3770

2001

Volltextzugriff (PDF)

Management strategies and outcomes for very elderly patients with diffuse large B‐cell lymphoma

Cancer, 2016-10, Vol.122 (20), p.3145-3151

2016

Volltextzugriff (PDF)

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

Blood cancer journal (New York), 2022-02, Vol.12 (2), p.25-25, Article 25

2022

Volltextzugriff (PDF)

Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma

Leukemia & lymphoma, 2013-12, Vol.54 (12), p.2631-2638

2013

Volltextzugriff (PDF)

Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP

Clinical lymphoma, myeloma and leukemia, 2018-01, Vol.18 (1), p.e103-e108

2018

Volltextzugriff (PDF)

Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas

Leukemia & lymphoma, 2012-01, Vol.53 (1), p.50-56

2012

Volltextzugriff (PDF)

Hodgkin's lymphoma in younger patients: lessons learned on the road to success

Oncology (Williston Park, N.Y.), 2007-04, Vol.21 (4), p.434

Hagemeister, Fredrick B

2007

Volltextzugriff (PDF)

Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study

Leukemia & lymphoma, 2012-05, Vol.53 (5), p.801-806

2012

Volltextzugriff (PDF)

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte‐predominant Hodgkin disease

Cancer, 2002-03, Vol.94 (6), p.1731-1738

2002

Volltextzugriff (PDF)

An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease

Cancer, 2002-12, Vol.95 (12), p.2534-2538

2002

Volltextzugriff (PDF)

Subdiaphragmatic stage I & II Hodgkin’s disease: long-term follow-up and prognostic factors

International journal of radiation oncology, biology, physics, 1998-07, Vol.41 (5), p.1047-1056

1998

Volltextzugriff (PDF)

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue

Cancer chemotherapy and pharmacology, 2002-05, Vol.49, p.S13-S20

HAGEMEISTER, Fredrick B

2002

Volltextzugriff (PDF)

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model

Journal of clinical oncology, 1991-05, Vol.9 (5), p.762-769

1991

Volltextzugriff (PDF)

Hodgkin's Disease: The Next Decade

Leukemia & lymphoma, 1996, Vol.21 (1-2), p.53-61

Hagemeister, Fredrick B.

1996

Volltextzugriff (PDF)

Small noncleaved cell lymphoma in adults: superior results for stages I-III disease

Journal of clinical oncology, 1990-04, Vol.8 (4), p.615-622

1990

Volltextzugriff (PDF)

Intermediate‐grade lymphomas treated with cyclophosphamide‐doxorubicin‐vincristine‐prednisone‐bleomycin alternated with cyclophosphamide‐methotrexate‐etoposide‐dexamethasone. Application of prognostic models to data analysis

Cancer, 1994-05, Vol.73 (9), p.2408-2416

1994

Volltextzugriff (PDF)

Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase

Leukemia & lymphoma, 1995, Vol.18 (1-2), p.87-92

1995

Volltextzugriff (PDF)

Prognostic factors in decision-making in the clinical management of Hodgkin's disease

Hematological oncology, 1988-07, Vol.6 (3), p.257-269

Hagemeister, Fredrick B.

1988

Volltextzugriff (PDF)

Prognostic factors for stage IV Hodgkin's disease treated with MOPP, with or without bleomycin

Cancer, 1985-02, Vol.55 (4), p.691-697

1985

Volltextzugriff (PDF)

Diagnosis and management of Hodgkin's disease in the adult

Cancer, 1983-06, Vol.51 (S12), p.2469-2476

1983

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaOncology

ThemaPrognosis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Middle Aged
(16)
Female
(15)
Male
(15)
Adult
(14)
Aged
(13)
Neoplasm Staging
(12)
Hematology
(11)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Chemotherapy
(8)
Combined Modality Therapy
(8)
Hodgkin Disease - Drug Therapy
(8)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(8)
Prednisone - Administration & Dosage
(8)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PD-L1 + macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma

Positron Emission Tomography/Computed Tomography Findings During Therapy Predict Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemotherapy Alone but Not in Those Who Receive Consolidation Radiation

Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma

The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP

Impact of High-Dose Chemotherapy on Peripheral T-Cell Lymphomas

Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL

Management strategies and outcomes for very elderly patients with diffuse large B‐cell lymphoma

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma

Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP

Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas

Hodgkin's lymphoma in younger patients: lessons learned on the road to success

Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte‐predominant Hodgkin disease

An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease

Subdiaphragmatic stage I & II Hodgkin’s disease: long-term follow-up and prognostic factors

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue

Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model

Hodgkin's Disease: The Next Decade

Small noncleaved cell lymphoma in adults: superior results for stages I-III disease

Intermediate‐grade lymphomas treated with cyclophosphamide‐doxorubicin‐vincristine‐prednisone‐bleomycin alternated with cyclophosphamide‐methotrexate‐etoposide‐dexamethasone. Application of prognostic models to data analysis

Risk Classification for Large Cell Lymphoma using Lactate Dehydrogenase, Beta-2 Microglobulin, and Thymidine Kinase

Prognostic factors in decision-making in the clinical management of Hodgkin's disease

Prognostic factors for stage IV Hodgkin's disease treated with MOPP, with or without bleomycin

Diagnosis and management of Hodgkin's disease in the adult

Aktive Filter

Suchergebnisse filtern